Use of eltrombopag in aplastic anemia in Europe
Jakob Passweg(University Hospital of Basel), Ranka Serventi‐Seiwerth(University Hospital Centre Zagreb), Constantijn J.M. Halkes(Radboud University Nijmegen), Étienne Lengliné(Assistance Publique – Hôpitaux de Paris), Andrea Patriarca(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Boris V. Afanasyev(First Pavlov State Medical University of St. Petersburg), Dirk‐Jan Eikema, Benedetto Bruno(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Daniela Onofrillo(Ospedale di Santo Spirito), Alice Garnier, Antonio M. Risitano(European Society for Blood and Marrow Transplantation), Matyas Ecsedi(University Hospital of Basel), Olivier Tournilhac, Edoardo Lanino(Istituto Giannina Gaslini), Bernard Drénou(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), Cora Knol-Bout(European Society for Blood and Marrow Transplantation), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Alicia Rovó(University Hospital of Bern), Carlo Dufour(Istituto Giannina Gaslini), Per Ljungman(Karolinska University Hospital), Régis Peffault de Latour(Hôpital Saint-Louis), Francesca Bonifazi(University of Bologna), Paul Bosman(European Society for Blood and Marrow Transplantation), Peter Dreger(Heidelberg University), Beatrice Drexler(University Hospital of Basel), Dražen Pulanić(University Hospital Centre Zagreb), Pietro Pioltelli(University of Milan), Sabrina Giammarco(Agostino Gemelli University Polyclinic), Alexei Maschan(Stichting Kinderoncologie Nederland)
Cited by 38
Related Papers
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Solid Cancers after Bone Marrow Transplantation
|New England Journal of Medicine|1997|968